Congo vs Cuba: The number of people with susceptibility test result for rifampicin
Congo
42.71
in 2021
Cuba
40.43
in 2021
Congo rank
122nd
Cuba rank
124th
The number of people with susceptibility test result for rifampicin over time
- Congo
- Cuba
How they compare
Congo currently reports 42.71 against 40.43 in Cuba, a difference of 2.28.
That makes Congo's figure about 1.1 times Cuba's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Cuba ahead.
Congo ranks 122nd and Cuba ranks 124th of 146 countries.
Across the 2 decades both report, Congo averaged higher in 1 and Cuba in 1.
Head to head by decade
| Decade | Congo | Cuba | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 15.4 | 66.38 | 50.98 | Cuba |
| 2020s | 71.35 | 45.55 | 25.81 | Congo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Congo or Cuba?
- Congo, at 42.71 against 40.43 in Cuba as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Congo and Cuba?
- 2.28, with Congo ahead.
- How many years of comparable data are there for Congo and Cuba?
- 5 years are reported by both, from 2017 to 2021.
- How do Congo and Cuba rank globally for the number of people with susceptibility test result for rifampicin?
- Congo ranks 122nd and Cuba ranks 124th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.